Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/InspireMD, Inc/ 10-Q

Quarterly Report · 10-Q

InspireMD, Inc

NSPRNASDAQEQUITYCurrent

Quarterly Report

Filed Aug 14, 2026Accepted Aug 14, 2026, 4:30 PM EDTCIK 1433607Accession 0001493152-26-038438
View company →Permanent SEC source ↗
Share

Company context

InspireMD seeks to utilize its proprietary MicroNet ™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.

Current securities

NSPRNASDAQ · EQUITY · Current
Historical securities (4)
NSPRWNASDAQ · WARRANT · Historical · closed Dec 3, 2024NSPR.WSAMEX · WARRANT · Historical · closed Jun 7, 2021NSPR.WS.BNYSE_AMERICAN · WARRANT · Historical · closed Jun 7, 2021NSPRZNASDAQ · WARRANT · Historical · closed Mar 14, 2022

Recent company filings

  1. 4 filingSep 23, 2026
  2. 4 filingSep 23, 2026
  3. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD DisclosureSep 21, 2026
  4. Results of Operations and Financial ConditionAug 17, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJul 29, 2026

As-filed source

Primary evidence
As filedOpen full document ↗